The global biosurgery market size was USD 12.4 Bn in 2021 and is anticipated to reach USD 21.2 Bn in 2031, growing at a rate of 5.5% from 2022 to 2031.
Global Biosurgery Market report from Global Insight Services is the single authoritative source of intelligence on Biosurgery Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Biosurgery is a medical procedure that comprises the use of natural, synthetic, or semi-synthetic materials to seal surgical incisions and wounds. It is majorly used for preventing excessive blood loss, providing adhesion for wound and tissue sealing, and repairing damaged tissue and bones. Biosurgeries are usually conducted through the various hemostatic sealants, soft tissue repair, bone graft substitutes, adhesion prevention, and staple line reinforcement products. They also utilize natural allografts, cultured epithelial autografts, cultured epithelial autografts, and xenografts for minimizing intra and post-operative complications and promoting faster recovery of the patients.
Get Access to A Free Sample Copy of Our Latest Report :https://www.globalinsightservices.com/request-sample/GIS10242
Market Trends and Drivers
The major factors boosting the growth of the biosurgery market is the increasing volume of surgeries and the growing prevalence of severe trauma injuries. Adhesion formation is a major post-surgical complication, which results in healthcare complications and generally requires repeat surgeries for the treatment of affected patients. Post-surgical adhesion formation leads to different complications in different surgeries, like severe abdominal pain in the case of abdominal surgeries, infertility in women after gynaecological surgeries, and physical impairment of patients after neurological surgeries. Considering the severe effects of post-surgery adhesion formation in patients, the importance of products such as adhesion barriers is increasing in the market. Also, considering the growth in the number of surgeries performed globally, the importance of these products will be more prominent in the forthcoming years.
Likewise, the growing adoption of advanced biosurgery products in emerging markets is also boosting the growth of the biosurgery market. The penetration of biosurgery products is increasing across emerging countries, specifically based in the Asia Pacific, Latin America, and the Middle East and Africa. In the coming years, countries such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the biosurgery market.
Global Biosurgery Market Segmentation
The report analyses the biosurgery market based on product, application, end-user, and regions.
Global Biosurgery Market by Product
On the basis of product, it is segmented into bone graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants and adhesives, adhesion barriers, and staple-line reinforcement agents. The bone graft substitutes segment is likely to dominate the market during the forecast period. The key factors such as the increasing use of bone-graft substitutes across different types of orthopedic surgeries as they reduced surgical time are propelling the market growth of the segment. The bone substitutes can be broadly categorized into bone grafts (autografts, allografts, xenografts), ceramics and growth factors. The ideal bone substitutes should be biocompatible and not evoke any adverse inflammatory response.
Major Players of the Global Biosurgery Market
The global biosurgery market report includes players such as Johnson & Johnson (US), Baxter International Inc. (US), Medtronic Plc (Ireland), Becton, Dickinson & Co. (US), B. Braun Melsungen AG (Germany), Stryker Corp. (US), Integra Lifesciences Holdings Corp. (US), CSL Ltd. (Australia), Hemostasis LLC. (US), Pfizer Inc. (US), Cyrolife Inc. (US), Zimmer Biomet (US), Kuros Biosciences AG (Switzerland), Orthofix Medical Inc. (US), Smiths & Nephew Plc. (UK), Tissue Regenix Group Plc (UK), Betatech Medical (Turkey), Meril Lifesciences Pvt. Ltd. (India), RTI Surgicals (US), Samyang Holdings Corp. (South Korea), Aroa Biosurgery Ltd. (New Zealand), Meyer-Haake GmbH (Germany), Biom’Up (France), BioCer Entwicklungs-GmbH (Germany), and Hannox International Corp. (Taiwan) among others.
Free Customization Available https://www.globalinsightservices.com/request-customization/GIS10242
With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
& transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/